Cargando…

Meta‐Analysis of the Diagnostic Efficiency of THSD7A‐AB for the Diagnosis of Idiopathic Membranous Nephropathy

Thrombospondin type I domain‐containing 7A (THSD7A), is a specific autoantigen of adult idiopathic membranous nephropathy (IMN), whose circulating antibody (THSD7A‐AB) represents a promising biomarker for diagnosis of IMN. The objective of this meta‐analysis is to investigate the diagnostic efficien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yipeng, Zheng, Shanshan, Ma, Chaoqun, Lian, Ying, Zheng, Xiaoli, Guan, Peizhong, Wang, Baobao, Gong, Xiaojie, Gao, Feng, Liang, Liming, Xu, Dongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607246/ https://www.ncbi.nlm.nih.gov/pubmed/33163223 http://dx.doi.org/10.1002/gch2.201900099

Ejemplares similares

An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN
por: Ren, Song, et al.
Publicado: (2018)

A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy
por: Wanderley, David Campos, et al.
Publicado: (2019)

Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy
por: Reinhard, Linda, et al.
Publicado: (2021)

A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy
por: Zhang, Pingna, et al.
Publicado: (2021)

Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient
por: Chen, Minjiang, et al.
Publicado: (2021)

Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study
por: Sharma, Shree G, et al.
Publicado: (2018)

Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia
por: Shirai, Sayuri, et al.
Publicado: (2019)

Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain
por: Fresquet, M., et al.
Publicado: (2020)

Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans
por: Lwezaula, Bingileki F, et al.
Publicado: (2021)

Thrombospondin Type 1 Domain-Containing 7A (THSD7A)-Associated Membranous Nephropathy Leading to Metastatic Neuroendocrine Carcinoma
por: Juarez, Angel, et al.
Publicado: (2023)

The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy
por: Manral, Pallavi, et al.
Publicado: (2022)

The Role of Anti-PLA(2)R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice
por: Smarz-Widelska, Iwona, et al.
Publicado: (2022)

THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity
por: Larsen, Christopher P, et al.
Publicado: (2016)

The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Du, Yu, et al.
Publicado: (2014)

Histological transition from minimal change disease to THSD7A-associated membranous nephropathy in a patient receiving long-term steroid treatment: A case report
por: Kojima, Aki, et al.
Publicado: (2023)

Expression of THSD7A in neoplasm tissues and its relationship with proteinuria
por: Xian, Li, et al.
Publicado: (2019)

The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2018)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy
por: Cui, W., et al.
Publicado: (2017)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension
por: Lu, Wanjun, et al.
Publicado: (2020)

Correction to: The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2019)

Role of Serum and Urine Biomarkers (PLA(2)R and THSD7A) in Diagnosis, Monitoring and Prognostication of Primary Membranous Glomerulonephritis
por: Maifata, Sadiq Mu’azu, et al.
Publicado: (2020)

Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection
por: Wang, Ruiqiang, et al.
Publicado: (2021)

Patient Age and the Prognosis of Idiopathic Membranous Nephropathy
por: Yamaguchi, Makoto, et al.
Publicado: (2014)

Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
por: Kennedy, Claire, et al.
Publicado: (2013)

Idiopathic Membranous Nephropathy and Treatment Related Complications
por: Uncanin, Snezana, et al.
Publicado: (2020)

Advances of the experimental models of idiopathic membranous nephropathy
por: Jiang, Han Xue, et al.
Publicado: (2020)

Association of gut microbiota with idiopathic membranous nephropathy
por: Li, Mengfei, et al.
Publicado: (2022)

Clinical observation and analysis of thyroid hormone levels in patients with idiopathic membranous nephropathy
por: Huang, Yu, et al.
Publicado: (2020)

Identification of THSD7B and PRMT9 mutations as risk factors for familial lung adenocarcinoma: A case report
por: Zhang, Qianqian, et al.
Publicado: (2023)

THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients
por: Yao, Zifu, et al.
Publicado: (2022)

Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity
por: Liu, Wenbin, et al.
Publicado: (2020)

Two cases of idiopathic membranous nephropathy treated with rituximab
por: Young Yoon, Jae, et al.
Publicado: (2013)

The Unpredictability of Idiopathic Membranous Nephropathy: An Illustrative Case Report
por: Levin, Murray L., et al.
Publicado: (2018)

Idiopathic membranous nephropathy in children: A case report
por: Cui, Kun-Hua, et al.
Publicado: (2022)

Non-diabetic urine glucose in idiopathic membranous nephropathy
por: Liu, Lingling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_liuftbaqbman6idfjtpmeafb28